Prevalence, distribution and antifungal susceptibility profiles of Candida parapsilosis, Candida orthopsilosis and Candida metapsilosis bloodstream isolates

Journal of Medical Microbiology

Volumn 61, Issue PART7, 2012, Pages 1003-1008

  Bonfietti, Lucas Xavier ^a   Martins, Marilena dos Anjos ^a   Szeszs, Maria Walderez ^a   Pukiskas, Sandra Brasil Stolf ^a   Purisco, Sonia Ueda ^a   Pimentel, Fabiana Cortez ^a   Pereira, Graziella Hanna ^a   Silva, Dayane Cristina ^a   Oliveira, Lidiane ^a   Melhem, Marcia de Souza Carvalho ^a  

^a INSTITUTO ADOLFO LUTZ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; CASPOFUNGIN; FLUCONAZOLE; ITRACONAZOLE;

ANTIFUNGAL RESISTANCE; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; BACTERIUM ISOLATE; BRAZIL; CANDIDA; CANDIDA METAPSILOSIS; CANDIDA ORTHOPSILOSIS; CANDIDA PARAPSILOSIS; CONTROLLED STUDY; CROSS RESISTANCE; FUNGAL DETECTION; HUMAN; HUMAN TISSUE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ANTIFUNGAL AGENTS; BRAZIL; CANDIDA; CANDIDEMIA; GENOTYPE; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR TYPING; MYCOLOGICAL TYPING TECHNIQUES; MYCOLOGY; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PREVALENCE;

EID: 84862676962     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.037812-0     Document Type: Article

References (44)

1. Almirante, B., Rodríguez, D., Cuenca-Estrella, M., Almela, M., Sanchez, F., Ayats, J., Alonso-Tarres, C., Rodriguez-Tudela, J. L., Pahissa, A. & Barcelona Candidemia Project Study Group (2006). Epidemiology, risk factors, and prognosis of Candida parapsilosis bloodstream infections: case-control population-based surveillance study of patients in Barcelona, Spain, from 2002 to 2003. J Clin Microbiol 44, 1681-1685.
2. Arendrup, M. C. (2010). Epidemiology of invasive candidiasis. Curr Opin Crit Care 16, 445-452.
3. Asadzadeh, M., Ahmad, S., Al-Sweih, N. & Khan, Z. U. (2009). Rapid molecular differentiation and genotypic heterogeneity among Candida parapsilosis and Candida orthopsilosis strains isolated from clinical specimens in Kuwait. J Med Microbiol 58, 745-752.
4. Chen, Y.-C., Lin, Y.-H., Chen, K.-W., Lii, J., Teng, H.-J. & Li, S.-Y. (2010). Molecular epidemiology and antifungal susceptibility of Candida parapsilosis sensu stricto, Candida orthopsilosis, and Candida metapsilosis in Taiwan. Diagn Microbiol Infect Dis 68, 284-292.
5. Colombo, A. L., Nucci, M., Park, B. J., Nouér, S. A., Arthington-Skaggs, B., da Matta, D. A., Warnock, D. & Morgan, J. for the Brazilian Network Candidemia Study (2006). Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centers. J Clin Microbiol 44, 2816-2823.
6. Cuenca-Estrella, M., Rodríguez-Tudela, J. L., Córdoba, S., Melhem, M. C., Szeszs, M. W., Castañeda, E., Martínez, G. & Gabastou, J. M. (2008). [Regional laboratory network for surveillance of invasive fungal infections and antifungal susceptibility in Latin America]. Rev Panam Salud Publica 23, 129-134 (in Spanish).
7. da Matta, D. A., de Almeida, L. P., Machado, A. M., Azevedo, A. C., Kusano, E. J., Travassos, N. F., Salomão, R & Colombo, A. L. (2007). Antifungal susceptibility of 1000 Candida bloodstream isolates to 5 antifungal drugs: results of a multicenter study conducted in São Paulo, Brazil, 1995-2003. Diagn Microbiol Infect Dis 57, 399-404.
8. de Toro, M., Torres, M. J., Maite, R. & Aznar, J. (2011). Characterization of Candida parapsilosis complex isolates. Clin Microbiol Infect 17, 418-424.
9. Ghannoum, M. A., Chen, A., Buhari, M., Chandra, J., Mukherjee, P. K., Baxa, D., Golembieski, A. & Vazquez, J.Á. (2009). Differential in vitro activity of anidulafungin, caspofungin and micafungin against Candida parapsilosis isolates recovered from a burn unit. Clin Microbiol Infect 15, 274-279.
10. Gleason, T. G., May, A. K., Caparelli, D., Farr, B. M. & Sawyer, R. G. (1997). Emerging evidence of selection of fluconazole-tolerant fungi in surgical intensive care units. Arch Surg 132, 1197-1202.
11. Gomez-Lopez, A., Alastruey-Izquierdo, A., Rodriguez, D., Almirante, B., Pahissa, A., Rodriguez-Tudela, J. L., Cuenca-Estrella, M. & Barcelona Candidemia Project Study Group (2008). Prevalence and susceptibility profile of Candida metapsilosis and Candida orthopsilosis: results from population-based surveillance of candidemia in Spain. Antimicrob Agents Chemother 52, 1506-1509.
12. Gonçalves, S. S., Amorim, C. S., Nucci, M., Padovan, A. C., Briones, M. R., Melo, A. S. & Colombo, A. L. (2010). Prevalence rates and antifungal susceptibility profiles of the Candida parapsilosis species complex: results from a nationwide surveillance of candidaemia in Brazil. Clin Microbiol Infect 16, 885-887.
13. Gudlaugsson, O., Gillespie, S., Lee, K., Vande Berg, J., Hu, J., Messer, S., Herwaldt, L., Pfaller, M. & Diekema, D. (2003). Attributable mortality of nosocomial candidemia, revisited. Clin Infect Dis 37, 1172-1177.
14. Horn, D. L., Neofytos, D., Anaissie, E. J., Fishman, J. A., Steinbach, W. J., Olyaei, A. J., Marr, K. A., Pfaller, M. A., Chang, C. H. & Webster, K. M. (2009). Epidemiology and outcomes of candidemia in 2019 patients: data from the Prospective Antifungal Therapy Alliance registry. Clin Infect Dis 48, 1695-1703.
15. Kocsubé, S., Tóth, M., Vágvölgyi, C., Dóczi, I., Pesti, M., Pócsi, I., Szabó, J. & Varga, J. (2007). Occurrence and genetic variability of Candida parapsilosis sensu lato in Hungary. J Med Microbiol 56, 190-195.
16. Krcmery, V. & Barnes, A. J. (2002). Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance. J Hosp Infect 50, 243-260.
17. Lasker, B. A., Butler, G. & Lott, T. J. (2006). Molecular genotyping of Candida parapsilosis group I clinical isolates by analysis of polymorphic microsatellite markers. J Clin Microbiol 44, 750-759.
18. Leroy, O., Gangneux, J. P., Montravers, P., Mira, J. P., Gouin, F., Sollet, J. P., Carlet, J., Reynes, J., Rosenheim, M. & other authors (2009). Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006). Crit Care Med 37, 1612-1618.
19. Lida, S., Imai, T., Oguri, T., Okuzumi, K., Yamanaka, A., Moretti-Branchini, M. L., Nishimura, K. & Mikami, Y. (2005). Genetic diversity of the internal transcribed spacers (ITS) and 5.8S rRNA genes among clinical isolates of Candida parapsilosis in Brazil and Japan. Nippon Ishinkin Gakkai Zasshi 46, 133-137.
20. Lin, D., Wu, L.-C., Rinaldi, M. G. & Lehmann, P. F. (1995). Three distinct genotypes within Candida parapsilosis from clinical sources. J Clin Microbiol 33, 1815-1821.
21. Lockhart, S. R., Messer, S. A., Pfaller, M. A. & Diekema, D. J. (2008). Geographic distribution and antifungal susceptibility of the newly described species Candida orthopsilosis and Candida metapsilosis in comparison to the closely related species Candida parapsilosis. J Clin Microbiol 46, 2659-2664.
22. Lopez, J., Pernot, C., Aho, S., Caillot, D., Vagner, O., Dalle, F., Durnet-Archeray, M. J., Chavanet, P. & Bonnin, A. (2001). Decrease in Candida albicans strains with reduced susceptibility to fluconazole following changes in prescribing policies. J Hosp Infect 48, 122-128.
23. Mirhendi, H., Bruun, B., Schønheyder, H. C., Christensen, J. J., Fuursted, K., Gahrn-Hansen, B., Johansen, H. K., Nielsen, L., Knudsen, J. D. & Arendrup, M. C. (2010). Molecular screening for Candida orthopsilosis and Candida metapsilosis among Danish Candida parapsilosis group blood culture isolates: proposal of a new RFLP profile for differentiation. J Med Microbiol 59, 414-420.
24. Morgan, J. (2005). Global trends in candidemia: review of reports from 1995-2005. Curr Infect Dis Rep 7, 429-439.
25. Moudgal, V., Little, T., Boikov, D. & Vazquez, J. A. (2005). Multiechinocandin- and multiazole-resistant Candida parapsilosis isolates serially obtained during therapy for prosthetic valve endocarditis. Antimicrob Agents Chemother 49, 767-769.
26. Oxman, D. A., Chow, J. K., Frendl, G., Hadley, S., Hershkovitz, S., Ireland, P., McDermott, L. A., Tsai, K., Marty, F. M. & other authors (2010). Candidaemia associated with decreased in vitro fluconazole susceptibility: is Candida speciation predictive of the susceptibility pattern? J Antimicrob Chemother 65, 1460-1465.
27. Pappas, P. G., Kauffman, C. A., Andes, D., Benjamin, D. K., Jr, Calandra, T. F., Edwards, J. E., Jr, Filler, S. G., Fisher, J. F., Kullberg, B. J. & other authors (2009). Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 48, 503-535.
28. Pereira, G. H., Müller, P. R., Szeszs, M. W., Levin, A. S. & Melhem, M. S. (2010). Five-year evaluation of bloodstream yeast infections in a tertiary hospital: the predominance of non-C. albicans Candida species. Med Mycol 48, 839-842.
29. Pfaller, M. A., Diekema, D. J., Jones, R. N., Sader, H. S., Fluit, A. C., Hollis, R. J., Messer, S. A. & SENTRY Participant Group (2001). International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY Antimicrobial Surveillance Program. J Clin Microbiol 39, 3254-3259.
30. Pfaller, M. A., Messer, S. A., Moet, G. J., Jones, R. N. & Castanheira, M. (2011). Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in Intensive Care Unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008-2009). Int J Antimicrob Agents 38, 65-69.
31. Pryce, T. M., Palladino, S., Price, D. M., Gardam, D. J., Campbell, P. B., Christiansen, K. J. & Murray, R. J. (2006). Rapid identification of fungal pathogens in BacT/ALERT, BACTEC, and BBL MGIT media using polymerase chain reaction and DNA sequencing of the internal transcribed spacer regions. Diagn Microbiol Infect Dis 54, 289-297.
32. Rex, J. H., Pfaller, M. A., Walsh, T. J., Chaturvedi, V., Espinel-Ingroff, A., Ghannoum, M. A., Gosey, L. L., Odds, F. C., Rinaldi, M. G. & other authors (2001). Antifungal susceptibility testing: practical aspects and current challenges. Clin Microbiol Rev 14, 643-658.
33. Rocco, T. R., Reinert, S. E. & Simms, H. H. (2000). Effects of fluconazole administration in critically ill patients: analysis of bacterial and fungal resistance. Arch Surg 135, 160-165.
34. Rodriguez-Tudela, J. L., Arendrup, M. C., Cuenca-Estrella, M., Donnelly, J. P. & Lass-Flor, C. (2010). EUCAST breakpoints for antifungals. Drug News Perspect 23, 93-97.
35. Shin, J. H., Shin, D. H., Song, J. W., Kee, S. J., Suh, S. P. & Ryang, D. W. (2001). Electrophoretic karyotype analysis of sequential Candida parapsilosis isolates from patients with persistent or recurrent fungemia. J Clin Microbiol 39, 1258-1263.
36. Silva, A. P., Miranda, I. M., Lisboa, C., Pina-Vaz, C. & Rodrigues, A. G. (2009). Prevalence, distribution, and antifungal susceptibility profiles of Candida parapsilosis, C. orthopsilosis, and C. metapsilosis in a tertiary care hospital. J Clin Microbiol 47, 2392-2397.
37. Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility Testing (EUCAST) (2008). EUCAST definitive document EDef 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts. Clin Microbiol Infect 14, 398-405.
38. Tavanti, A., Davidson, A. D., Gow, N. A., Maiden, M. C. & Odds, F. C. (2005). Candida orthopsilosis and Candida metapsilosis spp. nov. to replace Candida parapsilosis groups II and III. J Clin Microbiol 43, 284-292.
39. Tavanti, A., Hensgens, L. A., Ghelardi, E., Campa, M. & Senesi, S. (2007). Genotyping of Candida orthopsilosis clinical isolates by amplification fragment length polymorphism reveals genetic diversity among independent isolates and strain maintenance within patients. J Clin Microbiol 45, 1455-1462.
40. Tay, S. T., Na, S. L. & Chong, J. (2009). Molecular differentiation and antifungal susceptibilities of Candida parapsilosis isolated from patients with bloodstream infections. J Med Microbiol 58, 185-191.
41. Tortorano, A. M., Kibbler, C., Peman, J., Bernhardt, H., Klingspor, L. & Grillot, R. (2006). Candidaemia in Europe: epidemiology and resistance. Int J Antimicrob Agents 27, 359-366.
42. Trofa, D., Gácser, A. & Nosanchuk, J. D. (2008). Candida parapsilosis, an emerging fungal pathogen. Clin Microbiol Rev 21, 606-625.
43. van Asbeck, E., Clemons, K. V., Martinez, M., Tong, A.-J. & Stevens, D. A. (2008). Significant differences in drug susceptibility among species in the Candida parapsilosis group. Diagn Microbiol Infect Dis 62, 106-109.
44. Wey, S. B., Mori, M., Pfaller, M. A., Woolson, R. F. & Wenzel, R. P. (1988). Hospital-acquired candidemia. The attributable mortality and excess length of stay. Arch Intern Med 148, 2642-2645.